DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

48.17 0.21 (0.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $48.17 0.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.29
Previous Close $47.96
Daily Range $47.48 - $48.48
52-Week Range $39.18 - $57.49
Market Cap $79.5B
P/E Ratio 31.71
Dividend (Yield) $1.44 (2.9%)
Ex-Dividend Date
Dividend Pay Date
04/02/14
05/01/14
Volume 13,265,208
Average Daily Volume 8,732,377
Current FY EPS $1.77

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Portola's Betrixaban Study Design Published - Analyst Blog

Noteworthy ETF Inflows: XLV, JNJ, AMGN, BMY

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfat

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfate with Cobicistate

3 Stocks Reiterated As A Buy: BMY, LOW, CSCO

Encouraging Data from Bristol-Myers - Analyst Blog

Market Hustle: Stock Futures Flat Ahead of JPMorgan, Wells Fargo Earnings

Merck Up on Encouraging HCV Data - Analyst Blog

See More BMY News...

BMY's Top Competitors

BMY $48.17 (0.44%)
Current stock: BMY
JNJ $99.20 (2.12%)
Current stock: JNJ
NVS $83.79 (-0.05%)
Current stock: NVS
RHHBY $36.14 (-0.17%)
Current stock: RHHBY